Xtl Biopharmaceuticals (XTLB) EBT Growth (1y) (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) EBT Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 133.68% |
| Sep 30, 2024 | 103.48% |
| Jun 30, 2024 | -93.41% |
| Mar 31, 2024 | 152.77% |
| Dec 31, 2023 | 13.36% |
| Sep 30, 2023 | -9.12% |
| Jun 30, 2023 | -27.72% |
| Mar 31, 2023 | -281.62% |
| Dec 31, 2022 | 13.57% |
| Sep 30, 2022 | -13.44% |
| Jun 30, 2022 | 5.94% |
| Mar 31, 2022 | 318.10% |
| Dec 31, 2021 | -194.72% |
| Sep 30, 2021 | 689.86% |
| Jun 30, 2021 | -39.63% |
| Mar 31, 2021 | -234.10% |
| Dec 31, 2020 | 230.21% |
| Sep 30, 2020 | -121.77% |
| Jun 30, 2020 | -8.50% |
| Mar 31, 2020 | 186.93% |